top of page



  • Compile a list of current geriatric oncology research in Canada

  • Enter into dialogue with major cancer funding agencies (CIHR, CCSRI) to enhance focus on geriatric oncology research through requests for proposals  or other mechanisms and highlight gaps in prior/current research

  • Identify gaps in existing knowledge around drug safety/toxicity data for older adults that can be targets of secondary analyses of clinical studies and/or retrospective analyses of large drug databases

  • Establish network of experienced mentors and researchers who can serve as local/national resources to help others who are entering this field


  • Establish elder-specific clinic trials through the Canadian Clinical Trials Group (CCTG)

  • Stimulate more randomized controlled trials of interventions that evaluate their effect on patient-reported outcomes such as functional status and quality of life.

  • Integrate geriatric oncology within existing research structures

    • Add GA into RCTs that are opening soon

    • Establish a geriatric oncology committee to vet trial proposals coming through existing groups, such as the CCTG

    • Ensure new trial protocols include geriatric-specific measures both as predictor variables (GA domains, toxicity prediction or frailty screening tools) and outcomes (e.g. functional status, cognition)

    • Disseminate best practices for recruiting older adults into clinical trials


Clinical and Cost-Effectiveness of a Comprehensive Geriatric Assessment in Canada Elders Receiving Chemotherapy (5C study)

bottom of page